New therapy options for MRSA with respiratory infection/pneumonia.

Autores de IIS La Fe

• Paula Ramírez Galleymore

  Autor

• Laia Fenandez Barat

  Autor

• Antonio Torres Marti

  Autor

Grupos

• Infecciones Respiratorias

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is a frequent causative agent of nosocomial pneumonia. Because of important clinical consequences of inappropriate treatment, a current review of the potential modifications undergone by S. aureus and adaptation to new treatment options is necessary.